Imaging Atherosclerosis in Diabetes: Current State

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. 1.
   Narayan KM et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006;29(9):2114–6.CrossRefPubMedGoogle Scholar
2. 2.
   Wilson PW. Diabetes mellitus and coronary heart disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S89–100.CrossRefPubMedGoogle Scholar
3. 3.
   Giri S et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105(1):32–40.CrossRefPubMedGoogle Scholar
4. 4.
   Emerging Risk Factors Collaboration et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRefGoogle Scholar
5. 5.
   Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2(2):120–6.CrossRefPubMedGoogle Scholar
6. 6.
   Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21(7):1138–45.CrossRefPubMedGoogle Scholar
7. 7.
   Cabin HS, Roberts WC. Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized ("silent") previous acute myocardial infarction. Am J Cardiol. 1982;50(4):677–81.CrossRefPubMedGoogle Scholar
8. 8.
   Wackers FJ et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954–61.CrossRefPubMedGoogle Scholar
9. 9.
   Miller TD et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147(5):890–6.CrossRefPubMedGoogle Scholar
10. 10.
    Haffner SM et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–34.CrossRefPubMedGoogle Scholar
11. 11.
    Lotufo PA et al. DIabetes and all-cause and coronary heart disease mortality among us male physicians. Arch Intern Med. 2001;161(2):242–7.CrossRefPubMedGoogle Scholar
12. 12.
    Vaccaro O et al. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the multiple risk factor intervention trial. Arch Intern Med. 2004;164(13):1438–43.CrossRefPubMedGoogle Scholar
13. 13.
    Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324(7343):939–42.CrossRefPubMedPubMedCentralGoogle Scholar
14. 14.
    Bulugahapitiya U et al. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med. 2009;26(2):142–8.CrossRefPubMedGoogle Scholar
15. 15.
    Ardehali R et al. Screening patients for subclinical atherosclerosis with non-contrast cardiac CT. Atherosclerosis. 2007;192(2):235–42.CrossRefPubMedGoogle Scholar
16. 16.
    Rumberger JA et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995;92(8):2157–62.CrossRefPubMedGoogle Scholar
17. 17.
    Detrano R et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–45.CrossRefPubMedGoogle Scholar
18. 18.•
    Budoff MJ et al. A comparison of outcomes with coronary artery calcium scanning in unselected populations: the Multi-Ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf RECALL study (HNR). J Cardiovasc Comput Tomogr. 2013;7(3):182–91. This article evaluates role of CAC across 2 culturally diverse populations.CrossRefPubMedPubMedCentralGoogle Scholar
19. 19.
    Berman DS et al. Noninvasive imaging in assessment of the asymptomatic diabetic patient: is it of value? J Nucl Cardiol. 2016;23(1):37–41.CrossRefPubMedGoogle Scholar
20. 20.
    van den Hoogen IJ et al. Prognostic value of coronary computed tomography angiography in diabetic patients without chest pain syndrome. J Nucl Cardiol. 2016;23(1):24–36.CrossRefPubMedGoogle Scholar
21. 21.
    Malik S, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes. The Multi-Ethnic Study of Atherosclerosis. Diabetes Care. 2011;34(10):2285–90.Google Scholar
22. 22.
    Moebus S et al. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort—results of the Heinz Nixdorf Recall Study. Diabetologia. 2009;52(1):81–9.CrossRefPubMedGoogle Scholar
23. 23.
    Mielke CH, Shields JP, Broemeling LD. Coronary artery calcium, coronary artery disease, and diabetes. Diabetes Res Clin Pract. 2001;53(1):55–61.CrossRefPubMedGoogle Scholar
24. 24.
    Qu W et al. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care. 2003;26(3):905–10.CrossRefPubMedGoogle Scholar
25. 25.
    Raggi P et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43(9):1663–9.CrossRefPubMedGoogle Scholar
26. 26.
    Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care. 2001;24(2):335–8.CrossRefPubMedGoogle Scholar
27. 27.
    Starkman HS et al. Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care. 2003;26(2):433–6.CrossRefPubMedGoogle Scholar
28. 28.
    Dabelea D, et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003;52(11):2833–9.Google Scholar
29. 29.
    Wong ND et al. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care. 2005;28(6):1445–50.CrossRefPubMedGoogle Scholar
30. 30.
    Anand DV et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006;27(6):713–21.CrossRefPubMedGoogle Scholar
31. 31.
    Elkeles RS et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J. 2008;29(18):2244–51.CrossRefPubMedGoogle Scholar
32. 32.•
    Yeboah J et al. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis. 2014;236(2):411–7. This article evaluates role of CAC in patients with diabetes across 2 culturally diverse populations.CrossRefPubMedPubMedCentralGoogle Scholar
33. 33.
    Silverman MG et al. Potential implications of coronary artery calcium testing for guiding aspirin use among asymptomatic individuals with diabetes. Diabetes Care. 2012;35(3):624–6.CrossRefPubMedPubMedCentralGoogle Scholar
34. 34.••
    Min JK et al. Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals. Atherosclerosis. 2014;232(2):298–304. This article discusses role of CTA in risk prediction, discrimination and reclassification in patients with diabetes.CrossRefPubMedGoogle Scholar
35. 35.
    Hendel RC et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: a Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53(23):2201–29.CrossRefPubMedGoogle Scholar
36. 36.
    Gibbons RJ et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002;40(8):1531–40.CrossRefPubMedGoogle Scholar
37. 37.
    Taylor AJ et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for Cardiac Computed Tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2010;122(21):e525–55.CrossRefPubMedGoogle Scholar
38. 38.
    Greenland P et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50–103.CrossRefPubMedGoogle Scholar
39. 39.
    Valenti V et al. Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-year follow-up study of 9715 patients. Circulation. 2016;9(2), e003528.PubMedGoogle Scholar
40. 40.
    Budoff MJ, Raggi P. Coronary artery disease progression assessed by electron-beam computed tomography. Am J Cardiol. 2001;88(2A):46E–50.CrossRefPubMedGoogle Scholar
41. 41.
    Budoff MJ et al. Progression of coronary artery calcium predicts all-cause mortality. J Am Coll Cardiol Img. 2010;3(12):1229–36.CrossRefGoogle Scholar
42. 42.•
    Budoff MJ et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;61(12):1231–9. This paper, published in 2013, showed progression of CAC is associated with an increased risk for future hard and total CHD events in a large multicenter study with long follow-up time.CrossRefPubMedPubMedCentralGoogle Scholar
43. 43.
    Budoff MJ et al. Diabetes and progression of coronary calcium under the influence of statin therapy. Am Heart J. 2005;149(4):695–700.CrossRefPubMedGoogle Scholar
44. 44.
    Saremi A et al. Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2010;33(12):2642–7.CrossRefPubMedPubMedCentralGoogle Scholar
45. 45.•
    Gassett AJ et al. Risk factors for long-term coronary artery calcium progression in the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2015;4(8), e001726. This paper, published in 2015, showed progression of CAC is associated with an increased risk for future cardiovascular events in a large multicenter study with long follow-up time.CrossRefPubMedPubMedCentralGoogle Scholar
46. 46.
    Wong ND et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. J Am Coll Cardiol Img. 2012;5(4):358–66.CrossRefGoogle Scholar
47. 47.
    Budoff MJ et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52(21):1724–32.CrossRefPubMedGoogle Scholar
48. 48.
    Madaj PM et al. Identification of noncalcified plaque in young persons with diabetes: an opportunity for early primary prevention of coronary artery disease identified with low-dose coronary computed tomographic angiography. Acad Radiol. 2012;19(7):889–93.CrossRefPubMedPubMedCentralGoogle Scholar
49. 49.
    Kamimura M et al. Role of coronary CT angiography in asymptomatic patients with type 2 diabetes mellitus. Int Heart J. 2012;53(1):23–8.CrossRefPubMedGoogle Scholar
50. 50.
    Roos CJ et al. Comparison by computed tomographic angiography. The presence and extent of coronary arterial atherosclerosis in south asians versus caucasians with diabetes mellitus. Am J Cardiol. 2014;113(11):1782–7.CrossRefPubMedGoogle Scholar
51. 51.
    Halon DA, et al. Pulse pressure and coronary atherosclerosis in asymptomatic type 2 diabetes mellitus: a 64-channel cardiac computed tomography analysis. Int J Cardiol. 2010;143(1):63–71.Google Scholar
52. 52.
    Scholte AJHA et al. Different manifestations of coronary artery disease by stress SPECT myocardial perfusion imaging, coronary calcium scoring, and multislice CT coronary angiography in asymptomatic patients with type 2 diabetes mellitus. J Nucl Cardiol. 2008;15(4):503–9.CrossRefPubMedGoogle Scholar
53. 53.
    Park GM et al. Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol. 2014;113(5):765–71.CrossRefPubMedGoogle Scholar
54. 54.
    Muhlestein JB et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA. 2014;312(21):2234–43.CrossRefPubMedGoogle Scholar
55. 55.••
    Budoff MJ et al. Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: the Imaging Council of the American College of Cardiology. J Am Coll Cardiol Img. 2016;9(2):176–92. This article reviews the role of different non-invasive modalities for assessment asyptomatic diabetic patients.CrossRefGoogle Scholar